T cell cytokine gene polymorphisms in canine diabetes mellitus

Veterinary Immunology and Immunopathology

Volumn 128, Issue 1-3, 2009, Pages 137-146

  Short, Andrea D ^a   Catchpole, Brian ^b   Kennedy, Lorna J ^a   Barnes, Annette ^c   Lee, Andy C ^d   Jones, Chris A ^d   Fretwell, Neale ^d   Ollier, William E R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d WALTHAM CENTRE FOR PET NUTRITION   (United Kingdom)

Author keywords

Canine diabetes; IFN ; IL 10; IL 12 ; IL 4; Single nucleotide polymorphism

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIABETES MELLITUS; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DNA SEQUENCE; DOG; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; NONHUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ANIMALS; CASE-CONTROL STUDIES; CYTOKINES; DIABETES MELLITUS; DOG DISEASES; DOGS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; T-LYMPHOCYTES;

CANIS FAMILIARIS;

EID: 60549092293     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.10.301     Document Type: Article

References (33)

1. Adorini L. Interleukin 12 and autoimmune diabetes. Nat. Genet. 27 (2001) 131-132
2. Arif S., Tree T.I., Astill T.P., Tremble J.M., Bishop A.J., Dayan C.M., Roep B.O., and Peakman M. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113 (2004) 451-463
3. Berman M.A., Sandborg C.I., Wang Z., Imfeld K.L., Zaldivar Jr. F., Dadufalza V., and Buckingham B.A. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J. Immunol. 157 (1996) 4690-4696
4. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., MacMurray J., Meloni G.F., Lucarelli P., Pellecchia M., Eisenbarth G.S., Comings D., and Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36 (2004) 337-338
5. Bugawan T.L., Mirel D.B., Valdes A.M., Panelo A., Pozzilli P., and Erlich H.A. Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am. J. Hum. Genet. 72 (2003) 1505-1514
6. Catchpole B., Ristic J.M., Fleeman L.M., and Davison L.J. Canine diabetes mellitus: can old dogs teach us new tricks?. Diabetologia 48 (2005) 1948-1956
7. Hoenig M., and Dawe D.L. A qualitative assay for beta cell antibodies. Preliminary results in dogs with diabetes mellitus. Vet. Immunol. Immunopathol. 32 (1992) 195-203
8. Ide A., Kawasaki E., Abiru N., Sun F., Kobayashi M., Fukushima T., Takahashi R., Kuwahara H., Kita A., Oshima K., Uotani S., Yamasaki H., Yamaguchi Y., and Eguchi K. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J. Autoimmun. 22 (2004) 73-78
9. Ionescu-Tirgoviste C., Guja C., Herr M., Cucca E., Welsh K., Bunce M., Marshall S., and Todd J.A. Low frequency of HLA DRB1*03 - DQB1*02 and DQB1*0302 haplotypes in Romania is consistent with the country's low incidence of type I diabetes. Diabetologia 44 Suppl. 3 (2001) B60-B66
10. Jones E.Y., Fugger L., Strominger J.L., and Siebold C. MHC class II proteins and disease: a structural perspective. Nat. Rev. Immunol. 6 (2006) 271-282
11. Kennedy L.J., Davison L.J., Barnes A., Short A.D., Fretwell N., Jones C.A., Lee A.C., Ollier W.E., and Catchpole B. Identification of susceptibility and protective major histocompatibility complex haplotypes in canine diabetes mellitus. Tissue Antigens 68 (2006) 467-476
12. Kretowski A., Mironczuk K., Karpinska A., Bojaryn U., Kinalski M., Puchalski Z., and Kinalska I. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 51 (2002) 3347-3349
13. Lee Y.J., Lo F.S., Shu S.G., Wang C.H., Huang C.Y., Liu H.F., Wu C.C., Yang T.Y., and Chang J.G. The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 14 (2001) 383-388
14. Marmor M., Willeberg P., Glickman L.T., Priester W.A., Cypess R.H., and Hurvitz A.I. Epizootiologic patterns of diabetes mellitus in dogs. Am. J. Vet. Res. 43 (1982) 465-470
15. Mattheeuws D., Rottiers R., Kaneko J.J., and Vermeulen A. Diabetes mellitus in dogs: relationship of obesity to glucose tolerance and insulin response. Am. J. Vet. Res. 45 (1984) 98-103
16. Mojtahedi Z., Naeimi S., Farjadian S., Omrani G.R., and Ghaderi A. Association of IL-18 promoter polymorphisms with predisposition to type 1 diabetes. Diabet. Med. 23 (2006) 235-239
17. Park Y. Prediction of the risk of type 1 diabetes from polymorphisms in candidate genes. Diabetes Res. Clin. Pract. 66 Suppl. 1 (2004) S19-S25
18. Qu H., Tessier M.C., Hudson T.J., and Polychronakos C. Confirmation of the association of the R620W polymorphism in the protein tyrosine phosphatase PTPN22 with type 1 diabetes in a family based study. J. Med. Genet. 42 (2005) 266-270
19. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab. Rev. 14 (1998) 129-151
20. Raz I., Eldor R., and Naparstek Y. Immune modulation for prevention of type 1 diabetes mellitus. Trends Biotechnol. 23 (2005) 128-134
21. Ronningen K.S., Keiding N., and Green A. Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes. Diabetologia 44 Suppl. 3 (2001) B51-B59
22. Sham P.C., and Curtis D. Monte carlo tests for association between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 59 (1995) 97-105
23. Short, A.D., 2006. The genetics of canine diabetes: a candidate gene study.
24. Short A.D., Catchpole B., Kennedy L.J., Barnes A., Fretwell N., Jones C., Thomson W., and Ollier W.E. Analysis of candidate susceptibility genes in canine diabetes. J Hered. 98 5 (2007) 518-525
25. Short A.D., Kennedy L.J., Barnes A., Fretwell N., Jones C., Thomson W., and Ollier W.E. Hardy Weinberg expectations in canine breeds: implications for genetic studies. J. Hered. 98 (2007) 445-451
26. Steck A.K., Bugawan T.L., Valdes A.M., Emery L.M., Blair A., Norris J.M., Redondo M.J., Babu S.R., Erlich H.A., Eisenbarth G.S., and Rewers M.J. Association of non-HLA genes with type 1 diabetes autoimmunity. Diabetes 54 (2005) 2482-2486
27. Thorsby E., and Ronningen K.S. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36 (1993) 371-377
28. Trembleau S., Penna G., Bosi E., Mortara A., Gately M.K., and Adorini L. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181 (1995) 817-821
29. Turpeinen H., Laine A.P., Hermann R., Simell O., Veijola R., Knip M., and Ilonen J. A linkage analysis of the CTLA4 gene region in Finnish patients with type 1 diabetes. Eur. J. Immunogenet. 30 (2003) 289-293
30. Wassmuth R., and Lernmark A. The genetics of susceptibility to diabetes. Clin. Immunol. Immunopathol. 53 (1989) 358-399
31. Watson P.J., Roulois A.J., Scase T., Johnston P.E., Thompson H., and Herrtage M.E. Prevalence and breed distribution of chronic pancreatitis at post-mortem examination in first-opinion dogs. J. Small Anim. Pract. 48 (2007) 609-618
32. Zaccone P., Phillips J., Conget I., Gomis R., Haskins K., Minty A., Bendtzen K., Cooke A., and Nicoletti F. Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes 48 (1999) 1522-1528
33. Zalloua P.A., Abchee A., Shbaklo H., Zreik T.G., Terwedow H., Halaby G., and Azar S.T. Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene. Hum. Immunol. 65 (2004) 719-724